A Study of CriPec® Docetaxel Given to Patients With Solid Tumours

Clinical trial NCT02442531 · COMPLETED

Trial details

NCT number: NCT02442531
Sponsor: Cristal Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Metastatic Cancer Solid Tumors

Start date: 2015-08-01
Primary completion: 2018-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.